VEHRING, REINHARD,HARTMAN, MICHAEL STEVEN,LECHUGA-BALLESTEROS, DAVID,SMITH, ADRIAN EDWARD,JOSHI, VIDYA B.,DWIVEDI, SARVAJNA KUMAR
申请号：
PE0025182013
公开号：
PE04822014A1
申请日:
2011.05.17
申请国别(地区):
PE
年份:
2014
代理人:
摘要：
It relates to a method for treating a Lung Disease such as Asthma, chronic obstructive Disease (COPD), chronic bronchitis, emphysema, among others, which comprises administering a co suspension in the form of a pharmaceutically acceptable respirable aerosol, where such suspension contains co And (i) a suspension Medium comprising a propellant as PFCs, HFAAmong others (ii) two Active agents such as glycopyrrolate and formoterol and (iii) respirable suspended particles such as DSPC and Calcium chlorideSE REFIERE A UN METODO PARA TRATAR UNA ENFERMEDAD PULMONAR TAL COMO ASMA, ENFERMEDAD OBSTRUCTIVA CRONICA (COPD), BRONQUITIS CRONICA, ENFISEMA, ENTRE OTROS, QUE COMPRENDE ADMINISTRAR UNA CO-SUSPENSION FARMACEUTICAMENTE ACEPTABLE EN FORMA DE UN AEROSOL RESPIRABLE, EN DONDE DICHA CO-SUSPENSION CONTIENE i) UN MEDIO DE SUSPENSION QUE COMPRENDE UN PROPULSOR TAL COMO HFA, PFC, ENTRE OTROS ii) DOS AGENTES ACTIVOS TALES COMO GLICOPIRROLATO Y FORMOTEROL Y iii) PARTICULAS EN SUSPENSION RESPIRABLES TALES COMO DSPC Y CLORURO DE CALCIO
